Healthcare

Palmetto Pharm Selects Inovalon ScriptMed® To Improve Patient Outcomes and Streamline Operations

Inovalon's ScriptMed® Specialty Cloud-Based SaaS Solution Provides Data-Driven Analytics to Streamline Processes and Optimize Patient, Financial OutcomesBOWIE, Md., Jan. 22,…

8 months ago

SIRPant Immunotherapeutics Strengthens Board of Directors with Appointment of Roger Sawhney, M.D.

HUMMELSTOWN, Pa., Jan. 22, 2024 (GLOBE NEWSWIRE) -- SIRPant Immunotherapeutics, Inc., a clinical-stage immuno-oncology company focusing on developing next-generation macrophage-based…

8 months ago

MIMEDX Announces Improved Capital Structure with New Senior Secured Credit Facilities and Debt Refinancing

New Credit Facilities Provide Substantial Interest Savings and Access to Additional Capital to Support Execution of Strategic PrioritiesMARIETTA, Ga., Jan.…

8 months ago

CloudMD to Present at Maxim Healthcare Conference

Vancouver, British Columbia--(Newsfile Corp. - January 22, 2024) - CloudMD Software & Services Inc. (TSXV: DOC) (OTCQX: DOCRF) (FSE: 6PH)…

8 months ago

Evotec SE: Invitation to Conference Call

HAMBURG, GERMANY / ACCESSWIRE / January 22, 2024 / Evotec SE (Frankfurt Stock Exchange:EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ:EVO) is going…

8 months ago

Revolutionizing Healthcare: Remedy- House Calls Unveils Groundbreaking Platform for On-Demand, Personalized Care

New York, NY - Remedy - House Calls, a cutting-edge healthcare technology platform, is set to transform the landscape of…

8 months ago

InkSpace Imaging Announces Dr. E. Brian Welch, PhD, MBA as Vice President of Clinical Partnerships

PLEASANTON, Calif., Jan. 19, 2024 (GLOBE NEWSWIRE) -- InkSpace Imaging today announced the appointment of Dr. E. Brian Welch, PhD,…

8 months ago

Registration Opens for 2024 Robotics Summit & Expo

Registration is now open for the Robotics Summit & Expo, the world’s leading technical event for commercial robotics developers. The…

8 months ago

Vaxart Receives $9.27 Million BARDA Project NextGen Award to Prepare for Phase 2b Clinical Study Evaluating Its COVID-19 Oral Pill Vaccine Candidate

- 10,000-subject Phase 2b study would evaluate Vaxart’s next generation oral pill XBB COVID-19 vaccine against an approved mRNA vaccine…

8 months ago

MedBright AI to Present at CEM Bahamas Small-Cap Conference and Maxim Group’s 2024 Healthcare IT Conference

VANCOUVER, British Columbia, Jan. 19, 2024 (GLOBE NEWSWIRE) -- MedBright AI Investments Inc. (the “Company” or “MedBright”) (CSE:MBAI, OTCQB:MBAIF, FSE:1V7)…

8 months ago